To fight lymphoma, cancer patient first in Singapore to have T-cells genetically modified outside clinical trials

SINGAPORE — Cycling enthusiast Sam Tan used to ride up to 100km on weekends and was one of the fittest in his riding group. That all changed when the building maintenance and renovation contractor was diagnosed in 2017 with lymphoma, a type of blood cancer that affect a type of white blood cells called lymphocytes.